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houm prior to or el the t,no of hospitalization, A logistic model with 95% CI 
was utilized to Identify key predictors of one year mortality (pseudo R ~ with p 
< 0,0001), 
Results: In-hospital mortality wee 54% for pts with AMI end CA. Of 2782 
pie discharged alive, 25% {695) dted over the next year. Cardiac predictors 
of one,year mortality Included: the presence of sustelned or nonsustalned 
ventrloular te(~hyoerdta (VT) on the admission ECG (OR 1,85; el: 1,24, 2.78), 
prior CHF (OR 1,78; CI 1.27, 1,98), aortic etenosle (OR 1,51; el: 1,18, 1,93), 
end ~Inteffor MI (OR 1.35; Oh 1,12, 1,63), Noneardteo predictors In,lured: 
dementia (OR 1,78; GI: 1,20, 2,64), Immobility (OR 1.72; CI 139, 2,17), 
peripheral vascular disease (OR: 1,3g; el; 1,03, 1,90), diabetes (OR: t ,35; 
el: 1,09, 1,67), age (OR 1,25 pot 5.yeer Increment; CI 1,03, 1,38), and 
eraatlnlne (OR 1,~t~ p~r 0.1 Increment; CI 1,09, t.3B). 
Cor¢tuslona: The occurrence of VT as doeureonted on tho admission 
ECG was the most powedut predictor of one.year mortality; 2) Other eardtsc 
predictors of mortality Include anterior location of InferGtlon, prior CHE end 
aortic eteflosls; 3) Comorbld conditions ere also Important predictors of one 
year mortality; 4) Q wave MI, gender, race, smoking, nnd prior rovoscular. 
Izatlen were not e#soolated with an Incrattse In one year mort(dity in thpse 
pIs. 
• Smoking and Mortality Following Acute 
MyOcardial In!oration: RHul Ia  From the National 
Registry of  Myoc~rdkq In!oration 2 (NRMI 2) 
S,G, Gouday, H,V, Bsrmn, A,C. Rundte+ G~npnt~tl Ins,; Soi+th Snn 
Fmr¢ l~ USA 
~ck~r0~t~/: Current smokers have lower ~hort.torm orality following acute 
myocardial Intamtton (AMI) thnn non.smoke, m, This study explored possible 
explaneltlons of thle phenomet~on. 
Mefhod.~: From the 510,044 cases of AMI recorded by NRMI 2 from 
June 1,1994 through April 30, 1997, 297,458 cases without hospital transfer 
were selected for analysis, Multivariate logistic models investigated possible 
assoclstlons with In.hospital mortality using clinically relevant variables and 
Interaction teams, 
Results: Smoking was associated wlth decreased in-hospital mortalily 
(8,0% V~, 16,4%, p ~ 0,001), Smokers with AMI were younger than non- 
emoknm (mn~n age 58 ± 13 vs. 72 ~: 12 years, p .~ 0.001) and were 
more likely to suffer an inferior infarct (43% vs. 31%, p <. 0,001). The un- 
adjusted odds ratio for smoking and morality was, 0,44 (95% CI Q.43-O.45) 
and, after sequential adjustment for the following covadates became: ago, 
0,81 (95%Ct 0,78-..0.83); previous readiest hlstoryleardlovescular risk lec- 
tern, 0,86 (95%CI 0,83-0,89); and infarct location, 0,85 (98% CI 0,82-0,88) 
Adjustment for additional coverlates had little or no effect, 
Conclusion: Smokers with AMI wore on average 14 years younger lhan 
non4 ~nkore, explaining most of the apparent association of smoking with 
lower in-hospital mortalih/, The small residual association may have been 
duo to unmeasu~ confounding factors. 
• Long-Term (12-Year) Gender Differences In 
Prognosis After Acute Myocardial Infarction In 
Young (<65 Years) and Elderly (_>65 Years) 
Patients 
s. Gotttieb', M. Benderly. Ud Goldbourt, D. Harpaz, 
Henrietta Relcher-Reiss, S. Stem ~ , Elioser Kapltnsky, Solomon Bohar. For 
the SPRINT Study Group: Neufeld Cardiac Research Institute, Tel 
Hashomer, Israel: ' Bikur Chotim, Jerus~lera. Israel 
Background: Contreversy exists as to whether women (W) fare worse than 
men (M) after AML 
Methods; We studied the interrelationship between gender and age on 
the long-term prognosis (12-year) after AMI of 5839 pts (74% M) from the 
SPRINT Registry, In 1981-83, The pts were stratified by gender into 2 age 
groups: .~65 (n = 3065; 83% M) and _~65 yrs (n = 2774; 64% M). 
Results: In both age group, W were older tl',ah M, were more often diabetic 
and hypertensive, and tess often pts with prior MI or smokers. The in-hospital, 
5-yr and 12-yr postdischarge crude mortality rates and the RR of dying after 
adjustmg for pertinent variables including age revealed (Table): 
MoneGty - G5 yl~ >65 yrs 
M W R~ M W RR 
(n = 2539) in ~ 526) (95% CI) (n = 1776) in = 998) (95% CI) 
In-hospital 9% 18o,:, t.37 23% 31% 1,07 
(1,02--1,83) (0.89-1.29) 
5"yr post-discharge 17% ~9% 1,45 44% 47% 1,1l 
(1,1~-1.82) (0,96-129) 
t 2-yr post-discharge 39% S0% 1.21 76% 77% 1,09 
(1+03-1.43) (0,97-1.22) 
Conclusion: In Israel, In pts aged <65 yre, W had e significantly wome 
long.term prognosis after AMI then M, whereas, In pie aged -'-65, the differ- 
ence i, aortality between W and M wee considerably smaller, 
[ 1003-128 ] Long Term Outcome o f  Patients With non 
Q-Wave Myocardial Infarction With or Without 
Revseculnrlzatlon 
Z, Ghezzal, P, Ghelaalml, Y, Shaft, W,S. Welnlrnl.lb, 4Er#oty Uttivor~lty 
School of Medicine, Afl,~lnf~ Goorgl& (.I,%4 
The management of p~tlante who suffer a non O.w~ve myocardial In!oration 
la being debated. Thus we retrospectively analyzed 403 p~tlenI, with a ffocu. 
mented non Q.wave myocardial infarction within seven day~ of presentahen. 
Clinical characteristics and one and flv~ year emntlval for the throe treatment 
strategies am shown In the labia, In hospital death was less common in tim 
engtoplasty group compared to CABG (1.2% v/s &5%, p = 0,06), 
Medical PTCA CAQG p v~tua 
n (%) (n ,~ I~0) (n ;; 1(~0) [n .. 93) 
Prmr MI ~n tie%) ~2 (14%) 15 (16~) N$ 
Prim O^OG 30 t~0%) ~5 (16%) t~ (1~%) N~ 
PrlQr PTCA ~A (t~%) 31 (19%) 9 (IQ%) N~ 
Angina Clwss IV tO~ (68%i tt 3 (71%) (it (66%) N~ 
Cla~s III.CHF 13 (~P.} ~ (t 3%| 5 (6%) 0008 
Class IV.CHF t I (fi%) 3 (~'%) 6 (7%) 005 
3 Vl~sRel di~tt,~O 3(~ (~4%) 40 (~5%) 51 (55%) ~ 0 Q00I 
Ei(~CtiOl~ Fm~:tton 50 * 14 5~ ~ 11 51 t 13 NS 
one year 8t~% 9~% 88% NS 
,~ year= 6~% ;'0% m% NS 
Conclusion: In I~tionts who suffer a non Q myocardial infarclmn, manage. 
meat should be individualized. The long term survival between the medical 
and mvescularization groups is not statistically different. 
I 1003- !29 J  Plasma Adrsnomedul l in  as a Prognost ic 
Determinant Alter  Acute Myocardial  Infarct ion 
N. Nagoya, T. Nish&lmi. Y. Miyao. S. MiyazakL Y. Gofo. M Uematsu. 
K, Kangawa, H, NonogL National Cardiovascular Center, Osaka. Japan 
~ckground: Plasma adrenomedullin CAM), a novel vasorelaxant pep!ida, 
has been shown to increase in pmpertion to the clin¢al severity after acute 
myocardial infarction (MI). This study sought to elucidate whether AM can 
provide prognostic information independent of other determinants o! mortality 
after MI. 
Methods: Plasma AM on day 2 after MI was obtained from 80 patients with 
MI in addition to 23 clinical, hemodynamic, and cardiac functional vanables 
which were misted to the mortality. 
Results: Dunng a mean follow-up period el 19 months, 9 patients died 
el cardiac causes. AM on day 2 increased significantly in patients with MI 
compared with controls (13.3 • 11 vs 5.0 ± 2 pact/L, p < 0.0S)_ By univaftate 
analysi.% AM on day 2, age, corenary repedusion, pulmonary congestion, 
cardiac index, left ventncular ejection &action, and diuretics requirement 
were 011 significantly related to mortality. Among those variables, only AM 
was an independent predictor of mortality by muttivenate analysis using Cox 
proportional hazards model (p < 0.05). The Kaptan-Meier survival curves 
according to the 751h percentile value (15 pmol/L) of AM demonstrated that 
patients with high AM had a significantly lower survival rate than those with 
low AM (p < 0.001, F=guro). 
~'co':se: %~', i ~ :~ i5  pmol/L 
i , o  , , 
AM > I$ pmol/l ,  "~40' 
o b zoo ~ ~oo me tooo 
Time After the Onsel (day) 
Conclusions: Plasma AM on day 2 was strongly related to mortality in 
patients with MI and may provide prognostic information independent of 
clinical, hemodynaraic, and cardiac functional parameters. 
[ 003-130 ] Determinants o f  Left Ventrlcular Function After  1 
Anterior Myocardial  Infarction With Permanent 
Occlusion of  the Left Anter ior  Descending 
Artery 
R. Wolf, P R. Lichtlen, Bevensen Cardiac Rehabilitation Center and 
Hannover Medical School Germany 
Background: The relation between preceding angina pectoris (PAP), rheo- 
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logic blood plopertlas 8s indicated by plasma fibnnogen levels (FIB) and left 
ventrieular (LV) function after myocardial infarction (MI) remain underlain. 
Met t '~:  92 patients (pta) with proven anterior MI were investigated. NO 
inten~ntlonal or thrombolylic therapy was performed. Inclusion cntena were: 
1. Ilmtatad proximal occlusion of the kPft amOrlOr descending arfery (LAD) :,3 
weeks af1~ MI. 2, Remaining corona~/allerles and corresl:~Ondtng LV wall 
segmenl~ ~m nom~l. PI~. were ~ into 4 gro~ (gr.): 
gro~e PAP (~1 ~k)  F~B 
Re~lmfl~; Tbe 4 gr, were o:~mpafable regarding age, gender, age el MI and 
nsk fe¢toe~ Pts. m gf. 3 and 4 ~ more frequent ACE inh~bitom than gr. 
1 and 2 pts. LV eiect~ fraction (EF) deemase~ and the number 0! akinet~ 
~ ! S  (aS) ~.vea~ed from gr. ~ to4~ 
group l 2 3 4 
FIB (~)  2~03 ,tOt O" 2885 4187" 
(%) 6o.0 SO.a" S3:' ~. t "  
AS (%) S,~8 a3.a-- ~.7 ~.5-- 
2 p ~ O0~, g~. !~4:  p < O00~ 
Conci~u~: PAP has e ~ ~leet on ~ LV.func~on after ~qten(~" 
MI d~to  I ~  oedlJ~on of the L~D, I ~  by #~ d e ~  
of o~,)ary collatera~. This is a~,~ed by u~avomabee meofo~c blood 
i-..~p~,i:4is as indicated by ~ FiB ~ s .  Pts. without PAP and 
elevated FiB levets m at I ~  dsk for a targe MI and reduced LV-functon. 
Role of Non-Antlengina Drugs in Myocardial 
Is¢lterela 
Sunday, March 29, 1998, 5:00 p.m.-7:00 p.m. 
Georgia Wodd Congress Center, West Exhibit Hall Level 
Presentation Houri 5:00 p.m.-7:00 p.m. 
11004-1311 An~iotensin Converting Enzyme Inhibitor 
CaptopHI Does not  Improve Emrdse  Tolerance 
or  Reduce Exercise Induced Myocardial  
Ischemia in Patients With Anoina Pec lods  
U. Thadani, N. B~ar. Urmmrsil), of Oldahoma, Oklahoma Cd~. OK. USA 
Angiotensin is a potent coronary vasoconstnctor but reported effects of con- 
vetting enzyme inhib~Drs On exercise reduced myocardial ischemia am con- 
flicting. In a double-blind, ral~0mized crossover study, effects of ~ing~e oral 
doses of placebo, Captoprt| (CAPT) 25 mg and CAPT SO mg were eve~u- 
ated in 15 patients wdh exercise induced angina assemated with __.1 mm ST 
depmssioe. All antianginal o~ugs were discontinued and patmnts performed 
symptom limited treadmill exercise tests on 3 separate days before and I a~l 
4 hours after the administrations of the study drug. Compared to pre-drug 
baseline values, mean changes in seconds at t and 4 hours (h) post~Jose 
for various exercise variables were: 
Placebo CAPT 25 mg .... CAPT 25 mg 
th 4h lh  411 lh  4h 
Time to Angina +20 +5 + 1 - 6 +6 - 1 
Total Exerc-"~e "~me +1 -4 +8 -6 *6 -8 
"i~me tO t •rn ST ~ +8 -1 +14 +26 +21 +7 
Data show lack of improvement in exercise times or p.'olongation of time 
to myocardial ischemia after the two doses of CAPT compared to placebo. 
Above results were confirmed in another group of 27 patients who received 
CAPT 25 mg tid for 2 weeks followed by CAPT 50 mg tid for 4 weeks. These 
results suggest lhat CAPT does not exert any antianginal or anti-ischemic 
effects in patients with exercise induced angina. 
1004-1321 Angiotens in  II Receptor Antagonism Does Not 
Prevent Tolerance to Cont inuous Transdermal 
Nitroglycerin 
S.D. Milone, E.R. Azevedo, A.B. Parker, C. Forster, J.D. Parker. Universi~ 
of Toronto, Canada 
Background: Animal data suggests that nitrate tolerance may be caused by 
increased supemxtde an~ preduct~ and may be prevented w~ an ang~o, 
tensin II receptor (ATo antagar, st. We teared the h vpothas=s that tt~wapy 
with the ATt antagonist Lossflan wo~ld prevent he (~elopm~t of romance 
to cominuoua trfnsdermat nitr0glyeenn (TGTN) in humans. 
Method: Twemy normal mato vofur~e~m rece~ve~ Losa~an 75 rn~0ay 
or placebo in a ~ e ~ ,  double t~ind, pare, el ~ ,  A~,  I 
contlmmus TGTN 0,0 m0/hr wa~, glv~1 m ~tit lon to Losahan Of 
to ~11 v~lL.mt~r~. Standing SBP and e~upm~ fof~.asm ~ d i ~  
measumm~ta w~m ewlua~ and I~mmto¢~ was ~ as em m~l  
of p~asma vokm~e, Measurem~t~ were ma~e ~t ~ e ,  3 ~u~ foeow~ 
acute TGTN and 1 week after therapy with the ~t ton  of L0ea~m On= 
ptaee:be) ~nd "rGTN. 
Reeutt~'/leutaly, TGTN c~,~ a fall in SBP m both gr0tq~, Fo~,a~g 
sustain~ TGTN therapy, SBP was uret~lged from baseline m bath 
(Lo88d~n: 117 ~ 11 vs 111 -t 15 m~Hg; Placebo: 11"/' ± 11 w 115 ~ 12 
mmHg). Tolerance also ~ to 1he forearm venous r e ~  and 
not prevente~l by Lo~rfan 
Pm YGI'N Post ~ta~ TGTN 
L~sanan 070 ± 020" 025 • 023" 
' p.  0 05 vemus pm.,SLGTN ~p ~ 001 versus I~e-TGTN 
Hemato~tt decreased after acute TGTN and remained s ign i~t ly  dl. 
minished folk~mg suslamed TGTN therapy in both groups. 
Conc/u~on: Therapy wffh an angmlensin n ~or  antagonist ~ not 
prevent he devalo~ment m tolerarce tO the hemodynam¢ and venous ~ 
of TGTN. 
[loo.:1 1 =, 
Fill ing ~ure  aml ~ma Hormones for 
Advanced Progressive Remodel ing ~ Effect of  
Quinapdl  
I. Kugler, P. Gaudron, K. Hu, W. Bauer, C. Eilles, G. ErtL 2 ~ Medica/Clinic, 
Un~ver~y of Heidelberg at Mannheim, Germany 
B a ~  Progressive left vehicular (LV) ralatmn after myeeardml m- 
farclmn (MI) and h~gh norepmephnne in LV dysfunction cam/an adverse 
pro~-~o.31s. Our hypotl'te~s was that pmvefll]on of repetitwe rise of filling 
pressure and of plasma homlones during ordinary dmly mmrcme may be 
,mportant for pmvan~on of fu~er remodeling alter mfamtlon. 
MeU~ods: 25 pa1~mts with pmgresswe remodeling ware randomized (dou- 
ble-blied) to placebo (P, n = 13) or qufnapnl (Q. 10-40 mojday, n = 12). At 
baseline and follow-up (1, 6 and 12 months (M)) LV end-diastolic volume 
index (EDV1. ml/rn 2, gated SPECT), h o ~  (ANP, RIA. RTml; Nore- 
p~nephnne, HPLC, Wml) and LV titling pressure at rest and dunng I~cycte 
exerose equwalent vo dairy ordinary acbvmes (Swan-Ganz-catheter) were 
measureD. 
Resu/ts: LV dilation continued on P (della EDVI 6 M: 9 ± 2.2; 12 M: 26 
± 2.2) but not on Q (b M: 0.1 ± 2.5, 12 M I ± 2.5). Rme of wedge p~e-~ure 
with exerose dld not differ at baseline (Q: 20 ± 2, P: 21 ± 3) but was lower 
on Q (17 ± 1") compared to P (24 ± 5) at 12 M. At rest NOR decreased in 
O (322 ± 37. 420 ± 58, 238 ± 42, 270 ± 29 t , rANOVA p < 0.05 ,,Is 1 M) 
but not on P (331 ± 44. 422 ± 61,235 ± 31,284 ± 54). Rise of NOR on 
ese~se .=t 12 mo~ths was alleviated by O (baseline: 776 ± 103. 12 M: 476 
± 81. p < 0.05) compared to baseline, not on P (has.ins: 742 ± 157, 12 M: 
498 ± 101, n.s.). 
Conclusion: Prevention of further remodeling by O may be due to affen- 
uation of exercme induced rise of filling pressure and of exerose induced 
neurohumoral activahon (mean ± SEM; "p < 0.05 vs P). Thus, reduction of 
repetitive nse of filling pressure dunng dally ordinary activity may be tmpertant 
for prevention of progression of LV dilation by quinapnL 
I 1004-1341 Recovery of Myocyte Hypert rophy and Slippage 
Associated With the Left Vsntrtcumr Remodeling 
of  Myocardial Hibernation 
T. Lai, L Me, W.-C. Wu. D. Knibbs. D. Waters. C. Chen. Hartford Ho,~piral. 
Hartford. Connechcut. USA 
We have previously shown that LV remodeling occurs in hibernating my. 
ocardium (HM), with wall thinning related to slipaage of my0cyte bundles and 
myocyle hypertrophy. To study whether repedusion reverses these cellular 
changes, we created a LAD stenosis to reduce flow by ~ 4~ m 5 p~gs. 
producing severe regional LV dysfunction. At 7 days LV bi~p.~i=s were taken 
from the hibernating and normal regions; then the stenoses were released 
to reperfuse the HM and pigs were kept alive tar 4 weeks for recover. Con- 
trois consisted of 4 sham-operated pigs without stenoses. The number of 
myocytes per mm thickness of LV walt was counted and expressed as cell 
